MT
CRL icon

Midwest Trust’s Charles River Laboratories CRL Stock Holding History

Midwest Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.64M Buy
26,910
+28
+0.1% +$5.19K 0.06% 217
2025
Q4 		$5.36M Sell
26,882
-165
-0.6% -$29.9K 0.07% 205
2025
Q3 		$4.23M Buy
27,047
+906
+3% +$144K 0.06% 222
2025
Q2 		$3.97M Buy
+26,141
New +$3.49M 0.05% 222

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Midwest Trust's CRL Position: Q1 2026 in Review

Midwest Trust increased its Charles River Laboratories (CRL) stake by 0.1% in Q1 2026, buying an estimated $5.19K and bringing the position to 26,910 shares worth $4.64M. The position accounts for 0.06% of the portfolio, ranked #217.

Midwest Trust first reported a position in CRL in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.36M in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Midwest Trust held 26,910 shares of Charles River Laboratories worth $4.64M as of Q1 2026.
  • Midwest Trust bought 28 Charles River Laboratories shares in Q1 2026, an estimated $5.19K.
  • Charles River Laboratories made up 0.06% of Midwest Trust's portfolio in Q1 2026, its #217 holding.
  • Midwest Trust first reported a position in Charles River Laboratories in Q2 2025 and has held it in 4 quarters since.
  • Midwest Trust's Charles River Laboratories position peaked at $5.36M in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.